Reported covered position: Chief Counsel, Senate Environment and Public Works Committee (2021-2024), Senior Counsel, Senate Environment and Public Works Committee (2018-2021), Counsel, Senate Environment and Public Works Committee (2017-2018)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: FRAGRANCE CREATORS ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Policies related to corporate taxes and tax incentives, including research and experimentation expensing H.R. 1 (One Big Beautiful Bill Act), regarding implementation of corporate taxes and tax incentives, including research and experimentation expensing
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: FRAGRANCE CREATORS ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMRIZE NORTH AMERICA INC. via ARENTFOX SCHIFF LLP
2026 · second_quarter · Q2
40 CFR Part 63, Subpart EEE
Filing targets: Environmental Protection Agency (EPA)
AMERICAN ELECTRIC POWER COMPANY, INC. via ARENTFOX SCHIFF LLP
2026 · second_quarter · Q2
Source: Senate LDA
| THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 5 | 2024–2025 |
| ASSOCIATION OF AMERICAN RAILROADS | 4 | 2025 |
| BAUER COMPRESSORS, INC. | 4 | 2025–2026 |
| DURACELL US OPERATIONS, INC. | 4 | 2025–2026 |
| ORGANOGENESIS INC. | 4 | 2025–2026 |
| PURITAN MEDICAL PRODUCTS CO., LLC | 4 | 2025–2026 |
| INFECTIOUS DISEASES SOCIETY OF AMERICA | 3 | 2024–2025 |
| MENTAL HEALTH ASSOCIATION OF NEW YORK CITY, INC. (DBA VIBRANT EMOTIONAL HEALTH) | 3 | 2025 |
| AMERICAN ASSOCIATION OF TEACHING HEALTH CENTERS | 2 | 2024 |
| COMPUTER & COMMUNICATIONS INDUSTRY ASSOCIATION | 2 | 2025 |
| HOLCIM (US) INC. | 2 | 2025 |
| MEDALLIA, INC. | 2 | 2025–2026 |
| COOP CAREERS, INC. | 1 | 2025 |
| INTERNATIONAL RECYCLING GROUP (IRG) | 1 | 2025 |
| THERME GROUP US, LLC | 1 | 2025 |
Policies related to corporate taxes and tax incentives, including research and experimentation expensing H.R. 1 (One Big Beautiful Bill Act), regarding implementation of corporate taxes and tax incentives, including research and experimentation expensing
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: FRAGRANCE CREATORS ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Policies related to corporate taxes and tax incentives, including research and experimentation expensing H.R. 1 (One Big Beautiful Bill Act), regarding corporate taxes and tax incentives, including research and experimentation expensing
New Source Review Permitting Improvement Act
Client: AMERICAN ELECTRIC POWER COMPANY, INC. · Firm: ARENTFOX SCHIFF LLP
Environmental Protection Agency (EPA) greenhouse gas regulations under Section 111 of the Clean Air Act EPA regulations of coal combustion residuals and permitting programs EPA effluent limitation guidelines Executive actions to extend power plant operations, address grid reliability and energy demand, and related power sector issues H.R. 3898 (PERMIT Act), regarding Clean Water Act effluent limitation guidelines H.R. 3900 (Water Quality Technology Availability Act), regarding Clean Water Act effluent limitation guidelines H.R. 4776 (SPEED Act), regarding amendment to the National Environmental Policy Act H.R. 161 (New Source Review Permitting Improvement Act), regarding permitting reform PFAS and Comprehensive Environmental Response Compensation and Liability (CERCLA) Act, generally Siting and permitting reform, generally Endangered Species Act, regarding regulatory reform Clean Air Act, regarding legislative and regulatory reforms
New Source Review Permitting Improvement Act
Client: AMERICAN ELECTRIC POWER COMPANY, INC. · Firm: ARENTFOX SCHIFF LLP
Environmental Protection Agency (EPA) greenhouse gas regulations under Section 111 of the Clean Air Act EPA regulations of coal combustion residuals and permitting programs EPA effluent limitation guidelines Executive actions to extend power plant operations, address grid reliability and energy demand, and related power sector issues H.R. 3898 (PERMIT Act), regarding Clean Water Act effluent limitation guidelines H.R. 3900 (Water Quality Technology Availability Act), regarding Clean Water Act effluent limitation guidelines H.R. 4776 (SPEED Act), regarding amendment to the National Environmental Policy Act H.R. 161 (New Source Review Permitting Improvement Act), regarding permitting reform PFAS and Comprehensive Environmental Response Compensation and Liability (CERCLA) Act, regarding distribution of funds Siting and permitting reform, generally Endangered Species Act, regarding regulatory reform Clean Air Act, regarding legislative and regulatory reforms
Environmental Protection Agency (EPA) greenhouse gas regulations under Section 111 of the Clean Air Act EPA regulations of coal combustion residuals and permitting programs EPA effluent limitation guidelines Executive actions to extend power plant operations, address grid reliability and energy demand, and related power sector issues H.R. 3898 (PERMIT Act), regarding Clean Water Act effluent limitation guidelines H.R. 3900 (Water Quality Technology Availability Act), regarding Clean Water Act effluent limitation guidelines H.R. 4776 (SPEED Act), regarding amendment to the National Environmental Policy Act H.R. 161 (New Source Review Permitting Improvement Act), regarding permitting reform PFAS and Comprehensive Environmental Response Compensation and Liability (CERCLA) Act, regarding distribution of funds Siting and permitting reform, generally Endangered Species Act, regarding regulatory reform Clean Air Act, regarding legislative and regulatory reforms
Environmental Protection Agency (EPA) greenhouse gas regulations under Section 111 of the Clean Air Act EPA regulations of coal combustion residuals and permitting programs EPA effluent limitation guidelines Executive actions to extend power plant operations, address grid reliability and energy demand, and related power sector issues H.R. 3898 (PERMIT Act), regarding Clean Water Act effluent limitation guidelines H.R. 3900 (Water Quality Technology Availability Act), regarding Clean Water Act effluent limitation guidelines H.R. 4776 (SPEED Act), regarding amendment to the National Environmental Policy Act H.R. 161 (New Source Review Permitting Improvement Act), regarding permitting reform PFAS and Comprehensive Environmental Response Compensation and Liability (CERCLA) Act, generally Siting and permitting reform, generally Endangered Species Act, regarding regulatory reform Clean Air Act, regarding legislative and regulatory reforms
Water Quality Technology Availability Act
Client: AMERICAN ELECTRIC POWER COMPANY, INC. · Firm: ARENTFOX SCHIFF LLP
Environmental Protection Agency (EPA) greenhouse gas regulations under Section 111 of the Clean Air Act EPA regulations of coal combustion residuals and permitting programs EPA effluent limitation guidelines Executive actions to extend power plant operations, address grid reliability and energy demand, and related power sector issues H.R. 3898 (PERMIT Act), regarding Clean Water Act effluent limitation guidelines H.R. 3900 (Water Quality Technology Availability Act), regarding Clean Water Act effluent limitation guidelines H.R. 4776 (SPEED Act), regarding amendment to the National Environmental Policy Act H.R. 161 (New Source Review Permitting Improvement Act), regarding permitting reform PFAS and Comprehensive Environmental Response Compensation and Liability (CERCLA) Act, generally Siting and permitting reform, generally Endangered Species Act, regarding regulatory reform Clean Air Act, regarding legislative and regulatory reforms
Water Quality Technology Availability Act
Client: AMERICAN ELECTRIC POWER COMPANY, INC. · Firm: ARENTFOX SCHIFF LLP
Environmental Protection Agency (EPA) greenhouse gas regulations under Section 111 of the Clean Air Act EPA regulations of coal combustion residuals and permitting programs EPA effluent limitation guidelines Executive actions to extend power plant operations, address grid reliability and energy demand, and related power sector issues H.R. 3898 (PERMIT Act), regarding Clean Water Act effluent limitation guidelines H.R. 3900 (Water Quality Technology Availability Act), regarding Clean Water Act effluent limitation guidelines H.R. 4776 (SPEED Act), regarding amendment to the National Environmental Policy Act H.R. 161 (New Source Review Permitting Improvement Act), regarding permitting reform PFAS and Comprehensive Environmental Response Compensation and Liability (CERCLA) Act, regarding distribution of funds Siting and permitting reform, generally Endangered Species Act, regarding regulatory reform Clean Air Act, regarding legislative and regulatory reforms
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: FRAGRANCE CREATORS ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 4121 and S. 2256 (Agriculture, Rural Development, Food and Drug Administration, and Related AgenciesAppropriationsAct, 2026), regarding implementation of Modernization of Cosmetics Regulation Act (MoCRA) H.R. 5371 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026), Division F, Title V, regarding implementation of Modernization of Cosmetics Regulation Act (MoCRA)
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2026
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), regarding Federal Transit Administration funding Policies related to Mass Transit Account generally H.R.7148 (Consolidated Appropriations Act, 2026), Division D, Title I, regarding Federal Transit Administration funding
Energy and Water Development and Related Agencies Appropriations Act, 2026
Client: VISTRA CORP. · Firm: ARENTFOX SCHIFF LLP
H.R. 4553 and S. 3293 (Energy and Water Development and Related AgenciesAppropriationsAct, 2026), regarding funding for Joppa Plant decommissioning project H.R. 6938 (Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026), regarding funding for Joppa Plant decommissioning project Department of Energy contractual reimbursement obligations for Joppa Plant
Environmental Protection Agency (EPA) greenhouse gas regulations under Section 111 of the Clean Air Act EPA regulations of coal combustion residuals and permitting programs EPA effluent limitation guidelines Executive actions to extend power plant operations, address grid reliability and energy demand, and related power sector issues H.R. 3898 (PERMIT Act), regarding Clean Water Act effluent limitation guidelines H.R. 3900 (Water Quality Technology Availability Act), regarding Clean Water Act effluent limitation guidelines H.R. 4776 (SPEED Act), regarding amendment to the National Environmental Policy Act H.R. 161 (New Source Review Permitting Improvement Act), regarding permitting reform PFAS and Comprehensive Environmental Response Compensation and Liability (CERCLA) Act, regarding distribution of funds Siting and permitting reform, generally Endangered Species Act, regarding regulatory reform Clean Air Act, regarding legislative and regulatory reforms
Environmental Protection Agency (EPA) greenhouse gas regulations under Section 111 of the Clean Air Act EPA regulations of coal combustion residuals and permitting programs EPA effluent limitation guidelines Executive actions to extend power plant operations, address grid reliability and energy demand, and related power sector issues H.R. 3898 (PERMIT Act), regarding Clean Water Act effluent limitation guidelines H.R. 3900 (Water Quality Technology Availability Act), regarding Clean Water Act effluent limitation guidelines H.R. 4776 (SPEED Act), regarding amendment to the National Environmental Policy Act H.R. 161 (New Source Review Permitting Improvement Act), regarding permitting reform PFAS and Comprehensive Environmental Response Compensation and Liability (CERCLA) Act, generally Siting and permitting reform, generally Endangered Species Act, regarding regulatory reform Clean Air Act, regarding legislative and regulatory reforms
Safe Transit Accountability Act
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding issues related to passenger rail policy, including liability insurance, Private Activity Bonds, and transit project approval processes H.R. 4900 and S. 2945 (Safe Transit Accountability Act), entire bill
Safe Transit Accountability Act
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding issues related to passenger rail policy, including liability insurance, Private Activity Bonds, and transit project approval processes H.R. 4900 and S. 2945 (Safe Transit Accountability Act), entire bill H.R. 8870 (BUILD America 250 Act), entire bill
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: FRAGRANCE CREATORS ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 8646 (Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027), regarding implementation of Modernization of Cosmetics Regulation Act (MoCRA) H.R. 5371 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026), Division F, Title V, regarding implementation of Modernization of Cosmetics Regulation Act (MoCRA) H.R.9171 (Department of the Interior, Environment, and Related Agencies Appropriations Act, 2027), regarding continued implementation of TSCA's fee authority
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: FRAGRANCE CREATORS ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 4121 and S. 2256 (Agriculture, Rural Development, Food and Drug Administration, and Related AgenciesAppropriationsAct, 2026), regarding implementation of Modernization of Cosmetics Regulation Act (MoCRA) H.R. 5371 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026), Division F, Title V, regarding implementation of Modernization of Cosmetics Regulation Act (MoCRA)
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: FRAGRANCE CREATORS ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 8646 (Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027), regarding implementation of Modernization of Cosmetics Regulation Act (MoCRA) H.R. 5371 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026), Division F, Title V, regarding implementation of Modernization of Cosmetics Regulation Act (MoCRA) H.R.9171 (Department of the Interior, Environment, and Related Agencies Appropriations Act, 2027), regarding continued implementation of TSCA's fee authority
Skin Substitute Access and Payment Reform Act
Client: ORGANOGENESIS INC. · Firm: ARENTFOX SCHIFF LLP
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations and Discarded Products policy Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R.6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Skin Substitute Access and Payment Reform Act
Client: ORGANOGENESIS INC. · Firm: ARENTFOX SCHIFF LLP
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R.6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Advanced Wound Care and Regenerative Medicine Access and Reform Act
Client: ORGANOGENESIS INC. · Firm: ARENTFOX SCHIFF LLP
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R.6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Advanced Wound Care and Regenerative Medicine Access and Reform Act
Client: ORGANOGENESIS INC. · Firm: ARENTFOX SCHIFF LLP
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations and Discarded Products policy Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R.6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026
Client: VISTRA CORP. · Firm: ARENTFOX SCHIFF LLP
H.R. 4553 and S. 3293 (Energy and Water Development and Related AgenciesAppropriationsAct, 2026), regarding funding for Joppa Plant decommissioning project H.R. 6938 (Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026), regarding funding for Joppa Plant decommissioning project Department of Energy contractual reimbursement obligations for Joppa Plant
Consolidated Appropriations Act, 2026
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), regarding Federal Transit Administration funding Policies related to Mass Transit Account generally H.R.7148 (Consolidated Appropriations Act, 2026), Division D, Title I, regarding Federal Transit Administration funding
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
Client: FRAGRANCE CREATORS ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 8646 (Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027), regarding implementation of Modernization of Cosmetics Regulation Act (MoCRA) H.R. 5371 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026), Division F, Title V, regarding implementation of Modernization of Cosmetics Regulation Act (MoCRA) H.R.9171 (Department of the Interior, Environment, and Related Agencies Appropriations Act, 2027), regarding continued implementation of TSCA's fee authority
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
Client: FRAGRANCE CREATORS ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 8646 (Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027), regarding implementation of Modernization of Cosmetics Regulation Act (MoCRA) H.R. 5371 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026), Division F, Title V, regarding implementation of Modernization of Cosmetics Regulation Act (MoCRA) H.R.9171 (Department of the Interior, Environment, and Related Agencies Appropriations Act, 2027), regarding continued implementation of TSCA's fee authority
BUILD America 250 Act
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding issues related to passenger rail policy, including liability insurance, Private Activity Bonds, and transit project approval processes H.R. 4900 and S. 2945 (Safe Transit Accountability Act), entire bill H.R. 8870 (BUILD America 250 Act), entire bill
Energy and Water Development and Related Agencies Appropriations Act, 2027
Client: VISTRA CORP. · Firm: ARENTFOX SCHIFF LLP
H.R.9022 (Energy and Water Development and Related Agencies Appropriations Act, 2027), regarding funding for Joppa Plant decommissioning project Department of Energy contractual reimbursement obligations for Joppa Plant
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 9170 (Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027), regarding Federal Transit Administration funding Policies related to Mass Transit Account generally
Department of the Interior, Environment, and Related Agencies Appropriations Act, 2027
Client: FRAGRANCE CREATORS ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 8646 (Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027), regarding implementation of Modernization of Cosmetics Regulation Act (MoCRA) H.R. 5371 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026), Division F, Title V, regarding implementation of Modernization of Cosmetics Regulation Act (MoCRA) H.R.9171 (Department of the Interior, Environment, and Related Agencies Appropriations Act, 2027), regarding continued implementation of TSCA's fee authority
Department of the Interior, Environment, and Related Agencies Appropriations Act, 2027
Client: FRAGRANCE CREATORS ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 8646 (Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027), regarding implementation of Modernization of Cosmetics Regulation Act (MoCRA) H.R. 5371 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026), Division F, Title V, regarding implementation of Modernization of Cosmetics Regulation Act (MoCRA) H.R.9171 (Department of the Interior, Environment, and Related Agencies Appropriations Act, 2027), regarding continued implementation of TSCA's fee authority
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: FRAGRANCE CREATORS ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 4121 and S. 2256 (Agriculture, Rural Development, Food and Drug Administration, and Related AgenciesAppropriationsAct, 2026), regarding implementation of Modernization of Cosmetics Regulation Act (MoCRA) H.R. 5371 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026), Division F, Title V, regarding implementation of Modernization of Cosmetics Regulation Act (MoCRA)
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2026
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), regarding Federal Transit Administration funding Policies related to Mass Transit Account generally H.R.7148 (Consolidated Appropriations Act, 2026), Division D, Title I, regarding Federal Transit Administration funding
Skin Substitute Access and Payment Reform Act of 2025
Client: ORGANOGENESIS INC. · Firm: ARENTFOX SCHIFF LLP
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R.6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Skin Substitute Access and Payment Reform Act of 2025
Client: ORGANOGENESIS INC. · Firm: ARENTFOX SCHIFF LLP
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations and Discarded Products policy Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R.6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Safe Transit Accountability Act
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding issues related to passenger rail policy, including liability insurance, Private Activity Bonds, and transit project approval processes H.R. 4900 and S. 2945 (Safe Transit Accountability Act), entire bill
Safe Transit Accountability Act
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding issues related to passenger rail policy, including liability insurance, Private Activity Bonds, and transit project approval processes H.R. 4900 and S. 2945 (Safe Transit Accountability Act), entire bill H.R. 8870 (BUILD America 250 Act), entire bill
Energy and Water Development and Related Agencies Appropriations Act, 2026
Client: VISTRA CORP. · Firm: ARENTFOX SCHIFF LLP
H.R. 4553 and S. 3293 (Energy and Water Development and Related AgenciesAppropriationsAct, 2026), regarding funding for Joppa Plant decommissioning project H.R. 6938 (Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026), regarding funding for Joppa Plant decommissioning project Department of Energy contractual reimbursement obligations for Joppa Plant
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: INFECTIOUS DISEASES SOCIETY OF AMERICA · Firm: ARENTFOX SCHIFF LLP
Fiscal Year 2026 funding for Bio-Preparedness Workforce Pilot Program, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H. Con. Res 14, regarding funding for infectious diseases programs generally S. Con. Res 7, regarding funding for infectious diseases programs generally H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding funding for Infectious diseases programs FY 2025 funding for infectious diseases programs generally Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Fiscal Year 2026 funding for Federal Transit Administration programs H. Con. Res. 14, regarding Federal Transit Administration funding S. Con. Res. 7, regarding Federal Transit Administration funding H.R. 1 (One Big Beautiful Bill Act), regarding electric vehicles Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Fiscal Year 2026 funding for Federal Transit Administration programs H. Con. Res. 14, regarding Federal Transit Administration funding S. Con. Res. 7, regarding Federal Transit Administration funding H.R. 1 (One Big Beautiful Bill Act), regarding electric vehicles Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: FRAGRANCE CREATORS ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Policies related to corporate taxes and tax incentives, including research and experimentation expensing H.R. 1 (One Big Beautiful Bill Act), regarding corporate taxes and tax incentives, including research and experimentation expensing NOTE: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 1 (One Big Beautiful Bill Act), regarding electric vehicles H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), regarding Federal Transit Administration funding H. R. 5371 (Continuing Appropriations and Extensions Act, 2026), entire bill Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: FRAGRANCE CREATORS ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Policies related to corporate taxes and tax incentives, including research and experimentation expensing H.R. 1 (One Big Beautiful Bill Act), regarding corporate taxes and tax incentives, including research and experimentation expensing
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE CHILDREN'S HOSPITAL OF PHILADELPHIA · Firm: ARENTFOX SCHIFF LLP
H.R. 1 (One Big Beautiful Bill Act), Title VII, Subtitle B, Chapter 1, regarding Medicaid program reforms Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE CHILDREN'S HOSPITAL OF PHILADELPHIA · Firm: ARENTFOX SCHIFF LLP
Supplemental Nutrition Assistance Program generally Medicaid program reforms, including telemedicine and prior authorization issues Section 340B Drug Pricing program Drug pricing reforms generally Juvenile mental and behavioral health legislation generally "Food as medicine" nutrition programs generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Medicare "site neutral" payment policy generally Pediatric cancer research generally Pediatric access to cell and gene therapies generally National Institutes of Health program reforms generally H.R. 1 (One Big Beautiful Bill Act), Section 71115, regarding Medicaid provider taxes H.R. 1509 and S. 752 (Accelerating Kids Access to Care Act of 2025), all provisions Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Accelerating Kids’ Access to Care Act of 2025
Client: THE CHILDREN'S HOSPITAL OF PHILADELPHIA · Firm: ARENTFOX SCHIFF LLP
Supplemental Nutrition Assistance Program generally Medicaid program reforms, including telemedicine and prior authorization issues Section 340B Drug Pricing program Drug pricing reforms generally Juvenile mental and behavioral health legislation generally "Food as medicine" nutrition programs generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Medicare "site neutral" payment policy generally Pediatric cancer research generally Pediatric access to cell and gene therapies generally National Institutes of Health program reforms generally H.R. 1 (One Big Beautiful Bill Act), Section 71115, regarding Medicaid provider taxes H.R. 1509 and S. 752 (Accelerating Kids Access to Care Act of 2025), all provisions Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
New Source Review Permitting Improvement Act
Client: AMERICAN ELECTRIC POWER COMPANY, INC. · Firm: ARENTFOX SCHIFF LLP
Environmental Protection Agency (EPA) greenhouse gas regulations under Section 111 of the Clean Air Act EPA regulations of coal combustion residuals and permitting programs EPA effluent limitation guidelines Executive actions to extend power plant operations, address grid reliability and energy demand, and related power sector issues H.R. 3898 (PERMIT Act), regarding Clean Water Act effluent limitation guidelines H.R. 3900 (Water Quality Technology Availability Act), regarding Clean Water Act effluent limitation guidelines H.R. 4776 (SPEED Act), regarding amendment to the National Environmental Policy Act H.R. 161 (New Source Review Permitting Improvement Act), regarding permitting reform PFAS and Comprehensive Environmental Response Compensation and Liability (CERCLA) Act, regarding distribution of funds Siting and permitting reform, generally
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: MENTAL HEALTH ASSOCIATION OF NEW YORK CITY, INC. (DBA VIBRANT EMOTIONAL HEALTH) · Firm: ARENTFOX SCHIFF LLP
H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding funding for the 988 Suicide & Crisis Lifeline H.R. 912 and S. 1007 (9-8-8 Lifeline Cybersecurity Responsibility Act), regarding funding for the 988 Suicide & Crisis Lifeline Fiscal Year 2025 and 2026 Departments of Labor, Health and Human Services, and Education regarding funding for the 988 Suicide & Crisis Lifeline Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: INFECTIOUS DISEASES SOCIETY OF AMERICA · Firm: ARENTFOX SCHIFF LLP
Fiscal Year 2026 funding for Bio-Preparedness Workforce Pilot Program, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H. Con. Res 14, regarding funding for infectious diseases programs generally S. Con. Res 7, regarding funding for infectious diseases programs generally H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding funding for Infectious diseases programs FY 2025 funding for infectious diseases programs generally Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: MENTAL HEALTH ASSOCIATION OF NEW YORK CITY, INC. (DBA VIBRANT EMOTIONAL HEALTH) · Firm: ARENTFOX SCHIFF LLP
H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding funding for the 988 Suicide & Crisis Lifeline H.R. 912 and S. 1007 (9-8-8 Lifeline Cybersecurity Responsibility Act), regarding funding for the 988 Suicide & Crisis Lifeline Fiscal Year 2025 and 2026 Departments of Labor, Health and Human Services, and Education regarding funding for the 988 Suicide & Crisis Lifeline Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: FRAGRANCE CREATORS ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA)FY26 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, Title VI, regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA) Fiscal Year 2025 and 2026 Department of Agriculture funding regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA)FY26 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, Title VI, regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA) Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Children’s Hospital GME Support Reauthorization Act of 2025
Client: THE CHILDREN'S HOSPITAL OF PHILADELPHIA · Firm: ARENTFOX SCHIFF LLP
Supplemental Nutrition Assistance Program generally Medicaid program reforms, including telemedicine and prior authorization issues Section 340B Drug Pricing program Drug pricing reforms generally Juvenile mental and behavioral health legislation generally "Food as medicine" nutrition programs generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Medicare "site neutral" payment policy generally Pediatric cancer research generally Pediatric access to cell and gene therapies generally National Institutes of Health program reforms generally H.R. 1 (One Big Beautiful Bill Act), Section 71115, regarding Medicaid provider taxes H.R. 1509 and S. 752 (Accelerating Kids Access to Care Act of 2025), all provisions Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Children’s Hospital GME Support Reauthorization Act of 2025
Client: THE CHILDREN'S HOSPITAL OF PHILADELPHIA · Firm: ARENTFOX SCHIFF LLP
Supplemental Nutrition Assistance Program generally Medicaid program reforms, including telemedicine and prior authorization issues Section 340B Drug Pricing program Drug pricing reforms generally Juvenile mental and behavioral health legislation generally "Food as medicine" nutrition programs generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Medicare "site neutral" payment policy generally Pediatric cancer research generally Pediatric access to cell and gene therapies generally National Institutes of Health program reforms generally Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: MENTAL HEALTH ASSOCIATION OF NEW YORK CITY, INC. (DBA VIBRANT EMOTIONAL HEALTH) · Firm: ARENTFOX SCHIFF LLP
H.R. 2483 and S. 2121 (SUPPORT for Patients and Communities Reauthorization Act of 2025), regarding policies surrounding and impacting cybersecurity and the 988 Suicide & Crisis Lifeline Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
App Store Accountability Act
Client: COMPUTER & COMMUNICATIONS INDUSTRY ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
S. 836 (Children and Teens Online Privacy Protection Act), regarding online safety H.R. 3149 (App Store Accountability Act), regarding Competition Policy relating to antitrust enforcement H.R. 3209 (App Store Freedom Act), regarding Competition Policy relating to antitrust enforcement Draft legislation (American Innovation and Choice Online Act), regarding Competition Policy relating to antitrust enforcement Draft legislation (Open App Markets Act), regarding Competition Policy relating to antitrust enforcement Draft legislation (Journalism Competition and Preservation Act of 2023), regarding Competition Policy relating to antitrust enforcement Draft legislation (Kids Online Safety Act (KOSA)), regarding Competition Policy relating to antitrust enforcement Draft legislation (AMERICA Act or Advertising Middlemen Endangering Rigorous Internet Competition Accountability Act), regarding Competition Policy relating to antitrust enforcement Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
App Store Freedom Act
Client: COMPUTER & COMMUNICATIONS INDUSTRY ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
S. 836 (Children and Teens Online Privacy Protection Act), regarding online safety H.R. 3149 (App Store Accountability Act), regarding Competition Policy relating to antitrust enforcement H.R. 3209 (App Store Freedom Act), regarding Competition Policy relating to antitrust enforcement Draft legislation (American Innovation and Choice Online Act), regarding Competition Policy relating to antitrust enforcement Draft legislation (Open App Markets Act), regarding Competition Policy relating to antitrust enforcement Draft legislation (Journalism Competition and Preservation Act of 2023), regarding Competition Policy relating to antitrust enforcement Draft legislation (Kids Online Safety Act (KOSA)), regarding Competition Policy relating to antitrust enforcement Draft legislation (AMERICA Act or Advertising Middlemen Endangering Rigorous Internet Competition Accountability Act), regarding Competition Policy relating to antitrust enforcement Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Environmental Protection Agency (EPA) greenhouse gas regulations under Section 111 of the Clean Air Act EPA regulations of coal combustion residuals and permitting programs EPA effluent limitation guidelines Executive actions to extend power plant operations, address grid reliability and energy demand, and related power sector issues H.R. 3898 (PERMIT Act), regarding Clean Water Act effluent limitation guidelines H.R. 3900 (Water Quality Technology Availability Act), regarding Clean Water Act effluent limitation guidelines Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Environmental Protection Agency (EPA) greenhouse gas regulations under Section 111 of the Clean Air Act EPA regulations of coal combustion residuals and permitting programs EPA effluent limitation guidelines Executive actions to extend power plant operations, address grid reliability and energy demand, and related power sector issues H.R. 3898 (PERMIT Act), regarding Clean Water Act effluent limitation guidelines H.R. 3900 (Water Quality Technology Availability Act), regarding Clean Water Act effluent limitation guidelines H.R. 4776 (SPEED Act), regarding amendment to the National Environmental Policy Act H.R. 161 (New Source Review Permitting Improvement Act), regarding permitting reform PFAS and Comprehensive Environmental Response Compensation and Liability (CERCLA) Act, regarding distribution of funds Siting and permitting reform, generally
Environmental Protection Agency (EPA) greenhouse gas regulations under Section 111 of the Clean Air Act EPA regulations of coal combustion residuals and permitting programs EPA effluent limitation guidelines Executive actions to extend power plant operations, address grid reliability and energy demand, and related power sector issues H.R. 3898 (PERMIT Act), regarding Clean Water Act effluent limitation guidelines H.R. 3900 (Water Quality Technology Availability Act), regarding Clean Water Act effluent limitation guidelines H.R. 4776 (SPEED Act), regarding amendment to the National Environmental Policy Act NOTE: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
Water Quality Technology Availability Act
Client: AMERICAN ELECTRIC POWER COMPANY, INC. · Firm: ARENTFOX SCHIFF LLP
Environmental Protection Agency (EPA) greenhouse gas regulations under Section 111 of the Clean Air Act EPA regulations of coal combustion residuals and permitting programs EPA effluent limitation guidelines Executive actions to extend power plant operations, address grid reliability and energy demand, and related power sector issues H.R. 3898 (PERMIT Act), regarding Clean Water Act effluent limitation guidelines H.R. 3900 (Water Quality Technology Availability Act), regarding Clean Water Act effluent limitation guidelines H.R. 4776 (SPEED Act), regarding amendment to the National Environmental Policy Act H.R. 161 (New Source Review Permitting Improvement Act), regarding permitting reform PFAS and Comprehensive Environmental Response Compensation and Liability (CERCLA) Act, regarding distribution of funds Siting and permitting reform, generally
Water Quality Technology Availability Act
Client: AMERICAN ELECTRIC POWER COMPANY, INC. · Firm: ARENTFOX SCHIFF LLP
Environmental Protection Agency (EPA) greenhouse gas regulations under Section 111 of the Clean Air Act EPA regulations of coal combustion residuals and permitting programs EPA effluent limitation guidelines Executive actions to extend power plant operations, address grid reliability and energy demand, and related power sector issues H.R. 3898 (PERMIT Act), regarding Clean Water Act effluent limitation guidelines H.R. 3900 (Water Quality Technology Availability Act), regarding Clean Water Act effluent limitation guidelines Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Water Quality Technology Availability Act
Client: AMERICAN ELECTRIC POWER COMPANY, INC. · Firm: ARENTFOX SCHIFF LLP
Environmental Protection Agency (EPA) greenhouse gas regulations under Section 111 of the Clean Air Act EPA regulations of coal combustion residuals and permitting programs EPA effluent limitation guidelines Executive actions to extend power plant operations, address grid reliability and energy demand, and related power sector issues H.R. 3898 (PERMIT Act), regarding Clean Water Act effluent limitation guidelines H.R. 3900 (Water Quality Technology Availability Act), regarding Clean Water Act effluent limitation guidelines H.R. 4776 (SPEED Act), regarding amendment to the National Environmental Policy Act NOTE: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: FRAGRANCE CREATORS ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 4121 and S. 2256 (Agriculture, Rural Development, Food and Drug Administration, and Related AgenciesAppropriationsAct, 2026), regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA) H.R. 5371 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026), Division F, Title V, regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: FRAGRANCE CREATORS ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 4121 and S. 2256 (Agriculture, Rural Development, Food and Drug Administration, and Related AgenciesAppropriationsAct, 2026), regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA)FY26 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, Title VI, regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA) NOTE: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2026
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), regarding Federal Transit Administration funding H. R. 5371 (Continuing Appropriations and Extensions Act, 2026), entire bill Policies related to Mass Transit Account generally
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2026
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 1 (One Big Beautiful Bill Act), regarding electric vehicles H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), regarding Federal Transit Administration funding H. R. 5371 (Continuing Appropriations and Extensions Act, 2026), entire bill Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
Energy and Water Development and Related Agencies Appropriations Act, 2026
Client: VISTRA CORP. · Firm: ARENTFOX SCHIFF LLP
H.R. 4553 (Energy and Water Development and Related AgenciesAppropriationsAct, 2026), regarding funding for Joppa Plant decommissioning project NOTE: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
Energy and Water Development and Related Agencies Appropriations Act, 2026
Client: VISTRA CORP. · Firm: ARENTFOX SCHIFF LLP
H.R. 4553 and S. 3293 (Energy and Water Development and Related AgenciesAppropriationsAct, 2026), regarding funding for Joppa Plant decommissioning project H.R. 6938 (Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026), regarding funding for Joppa Plant decommissioning project
Environmental Protection Agency (EPA) greenhouse gas regulations under Section 111 of the Clean Air Act EPA regulations of coal combustion residuals and permitting programs EPA effluent limitation guidelines Executive actions to extend power plant operations, address grid reliability and energy demand, and related power sector issues H.R. 3898 (PERMIT Act), regarding Clean Water Act effluent limitation guidelines H.R. 3900 (Water Quality Technology Availability Act), regarding Clean Water Act effluent limitation guidelines H.R. 4776 (SPEED Act), regarding amendment to the National Environmental Policy Act H.R. 161 (New Source Review Permitting Improvement Act), regarding permitting reform PFAS and Comprehensive Environmental Response Compensation and Liability (CERCLA) Act, regarding distribution of funds Siting and permitting reform, generally
Environmental Protection Agency (EPA) greenhouse gas regulations under Section 111 of the Clean Air Act EPA regulations of coal combustion residuals and permitting programs EPA effluent limitation guidelines Executive actions to extend power plant operations, address grid reliability and energy demand, and related power sector issues H.R. 3898 (PERMIT Act), regarding Clean Water Act effluent limitation guidelines H.R. 3900 (Water Quality Technology Availability Act), regarding Clean Water Act effluent limitation guidelines H.R. 4776 (SPEED Act), regarding amendment to the National Environmental Policy Act NOTE: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
Safe Transit Accountability Act
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding and issues related to passenger rail policy, including liability insurance H.R. 4900 (Safe Transit Accountability Act), entire bill Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
Safe Transit Accountability Act
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding issues related to passenger rail policy, including liability insurance, Private Activity Bonds, and transit project approval processes H.R. 4900 and S. 2945 (Safe Transit Accountability Act), entire bill
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 1 (One Big Beautiful Bill Act), regarding electric vehicles H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), regarding Federal Transit Administration funding H. R. 5371 (Continuing Appropriations and Extensions Act, 2026), entire bill Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), regarding Federal Transit Administration funding H. R. 5371 (Continuing Appropriations and Extensions Act, 2026), entire bill Policies related to Mass Transit Account generally
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: FRAGRANCE CREATORS ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 4121 and S. 2256 (Agriculture, Rural Development, Food and Drug Administration, and Related AgenciesAppropriationsAct, 2026), regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA) H.R. 5371 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026), Division F, Title V, regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA)
Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026
Client: VISTRA CORP. · Firm: ARENTFOX SCHIFF LLP
H.R. 4553 and S. 3293 (Energy and Water Development and Related AgenciesAppropriationsAct, 2026), regarding funding for Joppa Plant decommissioning project H.R. 6938 (Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026), regarding funding for Joppa Plant decommissioning project
9–8–8 Lifeline Cybersecurity Responsibility Act
Client: MENTAL HEALTH ASSOCIATION OF NEW YORK CITY, INC. (DBA VIBRANT EMOTIONAL HEALTH) · Firm: ARENTFOX SCHIFF LLP
H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding funding for the 988 Suicide & Crisis Lifeline H.R. 912 and S. 1007 (9-8-8 Lifeline Cybersecurity Responsibility Act), regarding funding for the 988 Suicide & Crisis Lifeline Fiscal Year 2025 and 2026 Departments of Labor, Health and Human Services, and Education regarding funding for the 988 Suicide & Crisis Lifeline Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
9–8–8 Lifeline Cybersecurity Responsibility Act
Client: MENTAL HEALTH ASSOCIATION OF NEW YORK CITY, INC. (DBA VIBRANT EMOTIONAL HEALTH) · Firm: ARENTFOX SCHIFF LLP
H.R. 912 and S. 1007 (9-8-8 Lifeline Cybersecurity Responsibility Act), regarding funding for the 988 Suicide & Crisis Lifeline Fiscal Year 2026 Departments of Labor, Health and Human Services, and Education regarding funding for the 988 Suicide & Crisis Lifeline Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
9–8–8 Lifeline Cybersecurity Responsibility Act
Client: MENTAL HEALTH ASSOCIATION OF NEW YORK CITY, INC. (DBA VIBRANT EMOTIONAL HEALTH) · Firm: ARENTFOX SCHIFF LLP
H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding funding for the 988 Suicide & Crisis Lifeline H.R. 912 and S. 1007 (9-8-8 Lifeline Cybersecurity Responsibility Act), regarding funding for the 988 Suicide & Crisis Lifeline Fiscal Year 2025 and 2026 Departments of Labor, Health and Human Services, and Education regarding funding for the 988 Suicide & Crisis Lifeline Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
9–8–8 Lifeline Cybersecurity Responsibility Act
Client: MENTAL HEALTH ASSOCIATION OF NEW YORK CITY, INC. (DBA VIBRANT EMOTIONAL HEALTH) · Firm: ARENTFOX SCHIFF LLP
H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding funding for the 988 Suicide & Crisis Lifeline H.R. 912 and S. 1007 (9-8-8 Lifeline Cybersecurity Responsibility Act), regarding funding for the 988 Suicide & Crisis Lifeline Fiscal Year 2025 and 2026 Departments of Labor, Health and Human Services, and Education regarding funding for the 988 Suicide & Crisis Lifeline Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
9–8–8 Lifeline Cybersecurity Responsibility Act
Client: MENTAL HEALTH ASSOCIATION OF NEW YORK CITY, INC. (DBA VIBRANT EMOTIONAL HEALTH) · Firm: ARENTFOX SCHIFF LLP
H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding funding for the 988 Suicide & Crisis Lifeline H.R. 912 and S. 1007 (9-8-8 Lifeline Cybersecurity Responsibility Act), regarding funding for the 988 Suicide & Crisis Lifeline Fiscal Year 2025 and 2026 Departments of Labor, Health and Human Services, and Education regarding funding for the 988 Suicide & Crisis Lifeline Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
9–8–8 Lifeline Cybersecurity Responsibility Act
Client: MENTAL HEALTH ASSOCIATION OF NEW YORK CITY, INC. (DBA VIBRANT EMOTIONAL HEALTH) · Firm: ARENTFOX SCHIFF LLP
H.R. 912 and S. 1007 (9-8-8 Lifeline Cybersecurity Responsibility Act), regarding funding for the 988 Suicide & Crisis Lifeline Fiscal Year 2026 Departments of Labor, Health and Human Services, and Education regarding funding for the 988 Suicide & Crisis Lifeline Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: MENTAL HEALTH ASSOCIATION OF NEW YORK CITY, INC. (DBA VIBRANT EMOTIONAL HEALTH) · Firm: ARENTFOX SCHIFF LLP
H.R. 2483 and S. 2121 (SUPPORT for Patients and Communities Reauthorization Act of 2025), regarding policies surrounding and impacting cybersecurity and the 988 Suicide & Crisis Lifeline Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: FRAGRANCE CREATORS ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 4121 and S. 2256 (Agriculture, Rural Development, Food and Drug Administration, and Related AgenciesAppropriationsAct, 2026), regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA)FY26 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, Title VI, regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA) NOTE: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: FRAGRANCE CREATORS ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 4121 and S. 2256 (Agriculture, Rural Development, Food and Drug Administration, and Related AgenciesAppropriationsAct, 2026), regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA) H.R. 5371 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026), Division F, Title V, regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA)
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2026
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 1 (One Big Beautiful Bill Act), regarding electric vehicles H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), regarding Federal Transit Administration funding H. R. 5371 (Continuing Appropriations and Extensions Act, 2026), entire bill Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2026
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), regarding Federal Transit Administration funding H. R. 5371 (Continuing Appropriations and Extensions Act, 2026), entire bill Policies related to Mass Transit Account generally
Skin Substitute Access and Payment Reform Act of 2025
Client: ORGANOGENESIS INC. · Firm: ARENTFOX SCHIFF LLP
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill NOTE: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
Safe Transit Accountability Act
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding issues related to passenger rail policy, including liability insurance, Private Activity Bonds, and transit project approval processes H.R. 4900 and S. 2945 (Safe Transit Accountability Act), entire bill
Energy and Water Development and Related Agencies Appropriations Act, 2026
Client: VISTRA CORP. · Firm: ARENTFOX SCHIFF LLP
H.R. 4553 and S. 3293 (Energy and Water Development and Related AgenciesAppropriationsAct, 2026), regarding funding for Joppa Plant decommissioning project H.R. 6938 (Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026), regarding funding for Joppa Plant decommissioning project
Accelerating Kids’ Access to Care Act
Client: THE CHILDREN'S HOSPITAL OF PHILADELPHIA · Firm: ARENTFOX SCHIFF LLP
Supplemental Nutrition Assistance Program generally Medicaid program reforms, including telemedicine and prior authorization issues Section 340B Drug Pricing program Drug pricing reforms generally Juvenile mental and behavioral health legislation generally "Food as medicine" nutrition programs generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Medicare "site neutral" payment policy generally Pediatric cancer research generally Pediatric access to cell and gene therapies generally National Institutes of Health program reforms generally H.R. 1 (One Big Beautiful Bill Act), Section 71115, regarding Medicaid provider taxes H.R. 1509 and S. 752 (Accelerating Kids Access to Care Act of 2025), all provisions Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Children and Teens’ Online Privacy Protection Act
Client: COMPUTER & COMMUNICATIONS INDUSTRY ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
S. 836 (Children and Teens Online Privacy Protection Act), regarding online safety H.R. 3149 (App Store Accountability Act), regarding Competition Policy relating to antitrust enforcement H.R. 3209 (App Store Freedom Act), regarding Competition Policy relating to antitrust enforcement Draft legislation (American Innovation and Choice Online Act), regarding Competition Policy relating to antitrust enforcement Draft legislation (Open App Markets Act), regarding Competition Policy relating to antitrust enforcement Draft legislation (Journalism Competition and Preservation Act of 2023), regarding Competition Policy relating to antitrust enforcement Draft legislation (Kids Online Safety Act (KOSA)), regarding Competition Policy relating to antitrust enforcement Draft legislation (AMERICA Act or Advertising Middlemen Endangering Rigorous Internet Competition Accountability Act), regarding Competition Policy relating to antitrust enforcement Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Fiscal Year 2026 funding for Federal Transit Administration programs H. Con. Res. 14, regarding Federal Transit Administration funding S. Con. Res. 7, regarding Federal Transit Administration funding H.R. 1 (One Big Beautiful Bill Act), regarding electric vehicles Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: INFECTIOUS DISEASES SOCIETY OF AMERICA · Firm: ARENTFOX SCHIFF LLP
Fiscal Year 2026 funding for Bio-Preparedness Workforce Pilot Program, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H. Con. Res 14, regarding funding for infectious diseases programs generally S. Con. Res 7, regarding funding for infectious diseases programs generally H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding funding for Infectious diseases programs FY 2025 funding for infectious diseases programs generally Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
American Relief Act, 2025
Client: THE CHILDREN'S HOSPITAL OF PHILADELPHIA · Firm: ARENTFOX SCHIFF LLP
Medicaid program reforms, including telemedicine and prior authorization issues Section 340B Drug Pricing program, including H.R. 5378 (Lower Costs, More Transparency Act), Section 202 Drug pricing reforms generally Juvenile mental and behavioral health legislation generally "Food as medicine" nutrition programs generally H.R. 3884 and S. 1852 (Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023), all provisions H.R. 3391 (Gabriella Miller Kids First Research Act 2.0), all provisions H.R. 3887 (Childrens Hospital GME Support Reauthorization Act of 2023), all provisions Medicare "site neutral" payment policy generally, including H.R. 5378 (Lower Costs, More Transparency Act), Section 203 Pediatric cancer research generally Pediatric access to cell and gene therapies generally H.R. 4758 (Accelerating Kids Access to Care Act), all provisions H.R. 7213 (Autism Collaboration, Accountability, Research, Education, and Support Act of 2024), all provisions H.R. 8260 and S. 4350 (Hospital Inpatient Services Modernization Act), all provisions H.R. 10545 (American Relief Act, 2025), regarding HHS program funding and Medicaid program reform provisions National Institutes of Health program reforms generally S. 904 (Sickle Cell Disease Comprehensive Care Act), all provisions
American Relief Act, 2025
Client: AMERICAN ASSOCIATION OF TEACHING HEALTH CENTERS · Firm: ARENTFOX SCHIFF LLP
Implementation of the Teaching Health Center Graduate Medical Education (THCGME) program generally Reauthorization of the Teaching Health Center Graduate Medical Education (THCGME) program H.R. 5378 (Lower Costs, More Transparency Act), Section 301, regarding reauthorization of THCGME program S. 2840 (Bipartisan Primary Care and Health Workforce Act), Section 101, regarding reauthorization of THCGME program H.R. 10545 (American Relief Act, 2025), Division C, Title II, Sec. 3201, regarding funding for THCGME program
American Relief Act, 2025
Client: THE CHILDREN'S HOSPITAL OF PHILADELPHIA · Firm: ARENTFOX SCHIFF LLP
Medicaid program reforms, including telemedicine and prior authorization issues Section 340B Drug Pricing program, including H.R. 5378 (Lower Costs, More Transparency Act), Section 202 Drug pricing reforms generally Juvenile mental and behavioral health legislation generally "Food as medicine" nutrition programs generally H.R. 3884 and S. 1852 (Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023), all provisions H.R. 3391 (Gabriella Miller Kids First Research Act 2.0), all provisions H.R. 3887 (Childrens Hospital GME Support Reauthorization Act of 2023), all provisions Medicare "site neutral" payment policy generally, including H.R. 5378 (Lower Costs, More Transparency Act), Section 203 Pediatric cancer research generally Pediatric access to cell and gene therapies generally H.R. 4758 (Accelerating Kids Access to Care Act), all provisions H.R. 7213 (Autism Collaboration, Accountability, Research, Education, and Support Act of 2024), all provisions H.R. 8260 and S. 4350 (Hospital Inpatient Services Modernization Act), all provisions H.R. 10545 (American Relief Act, 2025), regarding HHS program funding and Medicaid program reform provisions National Institutes of Health program reforms generally S. 904 (Sickle Cell Disease Comprehensive Care Act), all provisions Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
American Relief Act, 2025
Client: AMERICAN ASSOCIATION OF TEACHING HEALTH CENTERS · Firm: ARENTFOX SCHIFF LLP
Implementation of the Teaching Health Center Graduate Medical Education (THCGME) program generally Reauthorization of the Teaching Health Center Graduate Medical Education (THCGME) program H.R. 5378 (Lower Costs, More Transparency Act), Section 301, regarding reauthorization of THCGME program S. 2840 (Bipartisan Primary Care and Health Workforce Act), Section 101, regarding reauthorization of THCGME program H.R. 10545 (American Relief Act, 2025), Division C, Title II, Sec. 3201, regarding funding for THCGME program Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Fiscal Year 2027 appropriations, regarding funding of coal combustion residuals program and environmental regulatory priorities
Environmental Protection Agency (EPA) greenhouse gas regulations under Section 111 of the Clean Air Act EPA regulations of coal combustion residuals and permitting programs EPA effluent limitation guidelines Executive actions to extend power plant operations, address grid reliability and energy demand, and related power sector issues H.R. 3898 (PERMIT Act), regarding Clean Water Act effluent limitation guidelines H.R. 3900 (Water Quality Technology Availability Act), regarding Clean Water Act effluent limitation guidelines H.R. 4776 (SPEED Act), regarding amendment to the National Environmental Policy Act H.R. 161 (New Source Review Permitting Improvement Act), regarding permitting reform PFAS and Comprehensive Environmental Response Compensation and Liability (CERCLA) Act, generally Siting and permitting reform, generally Endangered Species Act, regarding regulatory reform Clean Air Act, regarding legislative and regulatory reforms
Filing targets: Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
DURACELL US OPERATIONS, INC. via ARENTFOX SCHIFF LLP
2026 · second_quarter · Q2
Department of Energy funding for domestic battery materials processing and battery production activities Supply chain and trade issues related to battery inputs, materials, production and consumer end use Section 232 Tariffs on Steel and Aluminum, generally Section 45X Advanced Manufacturing Production Credit, generally
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ORGANOGENESIS INC. via ARENTFOX SCHIFF LLP
2026 · second_quarter · Q2
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations and Discarded Products policy Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R.6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VISTRA CORP. via ARENTFOX SCHIFF LLP
2026 · second_quarter · Q2
H.R.9022 (Energy and Water Development and Related Agencies Appropriations Act, 2027), regarding funding for Joppa Plant decommissioning project Department of Energy contractual reimbursement obligations for Joppa Plant
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
FRAGRANCE CREATORS ASSOCIATION via ARENTFOX SCHIFF LLP
2026 · second_quarter · 2A
Policies related to corporate taxes and tax incentives, including research and experimentation expensing H.R. 1 (One Big Beautiful Bill Act), regarding implementation of corporate taxes and tax incentives, including research and experimentation expensing
Permitting reform
H.R. 8646 (Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027), regarding implementation of Modernization of Cosmetics Regulation Act (MoCRA) H.R. 5371 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026), Division F, Title V, regarding implementation of Modernization of Cosmetics Regulation Act (MoCRA) H.R.9171 (Department of the Interior, Environment, and Related Agencies Appropriations Act, 2027), regarding continued implementation of TSCA's fee authority
Implementation of Modernization of Cosmetics Regulation Act (MoCRA) regarding cosmetics ingredients and products
FRAGRANCE CREATORS ASSOCIATION via ARENTFOX SCHIFF LLP
2026 · second_quarter · Q2
Policies related to corporate taxes and tax incentives, including research and experimentation expensing H.R. 1 (One Big Beautiful Bill Act), regarding implementation of corporate taxes and tax incentives, including research and experimentation expensing
Implementation of Modernization of Cosmetics Regulation Act (MoCRA) regarding cosmetics ingredients and products
Implementation of P.L. 114-182 (Frank R. Lautenberg Chemical Safety for the 21st Century Act), regarding provisions related to the approval of new chemicals and risk evaluations Impacts of trade issues on chemicals
BAUER COMPRESSORS, INC. via ARENTFOX SCHIFF LLP
2026 · second_quarter · Q2
Section 232 of the Trade Expansion Act of 1962, regarding tariffs involving steel and aluminum Expansion of domestic manufacturing capacity and exports Tariff issues with Europe, generally
Filing targets: HOUSE OF REPRESENTATIVES, U.S. Trade Representative (USTR)
AMERICAN PUBLIC TRANSPORTATION ASSOCIATION via ARENTFOX SCHIFF LLP
2026 · second_quarter · Q2
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding issues related to passenger rail policy, including liability insurance, Private Activity Bonds, and transit project approval processes H.R. 4900 and S. 2945 (Safe Transit Accountability Act), entire bill H.R. 8870 (BUILD America 250 Act), entire bill
H.R. 9170 (Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027), regarding Federal Transit Administration funding Policies related to Mass Transit Account generally
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAUER COMPRESSORS, INC. via ARENTFOX SCHIFF LLP
2026 · first_quarter · Q1
Section 232 of the Trade Expansion Act of 1962, regarding tariffs involving steel and aluminum Expansion of domestic manufacturing capacity and exports Tariff issues with Europe, generally
Support for domestic onshoring, generally Section 232 of the Trade Expansion Act of 1962, regarding tariffs involving steel and aluminum
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Maritime Administration (MARAD), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), U.S. Trade Representative (USTR)
AMRIZE NORTH AMERICA INC. via ARENTFOX SCHIFF LLP
2026 · first_quarter · Q1
Clean Air Act compliance and enforcement matters concerning Paulding Cement Plant and broader issues related to 40 CFR Part 63, Subpart EEE
Filing targets: Environmental Protection Agency (EPA)
VISTRA CORP. via ARENTFOX SCHIFF LLP
2026 · first_quarter · Q1
H.R. 4553 and S. 3293 (Energy and Water Development and Related AgenciesAppropriationsAct, 2026), regarding funding for Joppa Plant decommissioning project H.R. 6938 (Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026), regarding funding for Joppa Plant decommissioning project Department of Energy contractual reimbursement obligations for Joppa Plant
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
FRAGRANCE CREATORS ASSOCIATION via ARENTFOX SCHIFF LLP
2026 · first_quarter · Q1
H.R. 4121 and S. 2256 (Agriculture, Rural Development, Food and Drug Administration, and Related AgenciesAppropriationsAct, 2026), regarding implementation of Modernization of Cosmetics Regulation Act (MoCRA) H.R. 5371 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026), Division F, Title V, regarding implementation of Modernization of Cosmetics Regulation Act (MoCRA)
Implementation of Modernization of Cosmetics Regulation Act (MoCRA) regarding cosmetics ingredients and products
MEDALLIA, INC. via ARENTFOX SCHIFF LLP
2026 · first_quarter · Q1
Issues related to government compliance, government waste, federal government contracts
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Labor, Dept of (DOL), SENATE, Treasury, Dept of, White House Office
CITY OF SPRINGFIELD, OFFICE OF PUBLIC UTILITIES DBA CITY WATER, LIGHT AND POWER via ARENTFOX SCHIFF LLP
2026 · first_quarter · Q1
EPA Clean Water Act pretreatment standards applicable to CWLP operations
Filing targets: Environmental Protection Agency (EPA)
PURITAN MEDICAL PRODUCTS CO., LLC via ARENTFOX SCHIFF LLP
2026 · first_quarter · Q1
Issues related to the PREP Act, which provides liability immunity for medical countermeasures during public health emergencies
Filing targets: Council of Economic Advisers (CEA), Executive Office of the President (EOP), White House Office
DURACELL US OPERATIONS, INC. via ARENTFOX SCHIFF LLP
2026 · first_quarter · Q1
Department of Energy funding for domestic battery materials processing and battery production activities Supply chain and trade issues related to battery inputs, materials, production and consumer end use
Filing targets: Energy, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ORGANOGENESIS INC. via ARENTFOX SCHIFF LLP
2026 · first_quarter · Q1
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R.6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN PUBLIC TRANSPORTATION ASSOCIATION via ARENTFOX SCHIFF LLP
2026 · first_quarter · Q1
H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), regarding Federal Transit Administration funding Policies related to Mass Transit Account generally H.R.7148 (Consolidated Appropriations Act, 2026), Division D, Title I, regarding Federal Transit Administration funding
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding issues related to passenger rail policy, including liability insurance, Private Activity Bonds, and transit project approval processes H.R. 4900 and S. 2945 (Safe Transit Accountability Act), entire bill
Filing targets: Council on Environmental Quality (CEQ), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ELECTRIC POWER COMPANY, INC. via ARENTFOX SCHIFF LLP
2026 · first_quarter · Q1
Environmental Protection Agency (EPA) greenhouse gas regulations under Section 111 of the Clean Air Act EPA regulations of coal combustion residuals and permitting programs EPA effluent limitation guidelines Executive actions to extend power plant operations, address grid reliability and energy demand, and related power sector issues H.R. 3898 (PERMIT Act), regarding Clean Water Act effluent limitation guidelines H.R. 3900 (Water Quality Technology Availability Act), regarding Clean Water Act effluent limitation guidelines H.R. 4776 (SPEED Act), regarding amendment to the National Environmental Policy Act H.R. 161 (New Source Review Permitting Improvement Act), regarding permitting reform PFAS and Comprehensive Environmental Response Compensation and Liability (CERCLA) Act, regarding distribution of funds Siting and permitting reform, generally Endangered Species Act, regarding regulatory reform Clean Air Act, regarding legislative and regulatory reforms
Fiscal Year 2027 appropriations, regarding funding of coal combustion residuals program and environmental regulatory priorities
DURACELL US OPERATIONS, INC. via ARENTFOX SCHIFF LLP
2025 · fourth_quarter · Q4
Department of Energy funding for domestic battery materials processing and battery production activities
Filing targets: HOUSE OF REPRESENTATIVES
AMRIZE NORTH AMERICA INC. via ARENTFOX SCHIFF LLP
2025 · fourth_quarter · Q4
Clean Air Act compliance and enforcement matters concerning Paulding Cement Plant and broader issues related to 40 CFR Part 63, Subpart EEE
Filing targets: Environmental Protection Agency (EPA)
BAUER COMPRESSORS, INC. via ARENTFOX SCHIFF LLP
2025 · fourth_quarter · Q4
Section 232 of the Trade Expansion Act of 1962, regarding tariffs involving steel and aluminum
Support for domestic onshoring, generally Section 232 of the Trade Expansion Act of 1962, regarding tariffs involving steel and aluminum
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Maritime Administration (MARAD), Natl Aeronautics & Space Administration (NASA), SENATE, Transportation, Dept of (DOT)
VISTRA CORP. via ARENTFOX SCHIFF LLP
2025 · fourth_quarter · Q4
H.R. 4553 and S. 3293 (Energy and Water Development and Related AgenciesAppropriationsAct, 2026), regarding funding for Joppa Plant decommissioning project H.R. 6938 (Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026), regarding funding for Joppa Plant decommissioning project
Filing targets: SENATE
PURITAN MEDICAL PRODUCTS CO., LLC via ARENTFOX SCHIFF LLP
2025 · fourth_quarter · Q4
Issues related to the PREP Act, which provides liability immunity for medical countermeasures during public health emergencies
Filing targets: Council of Economic Advisers (CEA), Executive Office of the President (EOP), White House Office
MEDALLIA, INC. via ARENTFOX SCHIFF LLP
2025 · fourth_quarter · Q4
Issues related to government compliance, government waste, federal government contracts
Filing targets: Agriculture, Dept of (USDA), Defense, Dept of (DOD), Education, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE, Social Security Administration (SSA), State, Dept of (DOS), Treasury, Dept of, White House Office
FRAGRANCE CREATORS ASSOCIATION via ARENTFOX SCHIFF LLP
2025 · fourth_quarter · Q4
Implementation of Modernization of Cosmetics Regulation Act (MOCRA) regarding cosmetics ingredients and products
Policies related to corporate taxes and tax incentives, including research and experimentation expensing H.R. 1 (One Big Beautiful Bill Act), regarding corporate taxes and tax incentives, including research and experimentation expensing
H.R. 4121 and S. 2256 (Agriculture, Rural Development, Food and Drug Administration, and Related AgenciesAppropriationsAct, 2026), regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA) H.R. 5371 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026), Division F, Title V, regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA)
CITY OF SPRINGFIELD, OFFICE OF PUBLIC UTILITIES DBA CITY WATER, LIGHT AND POWER via ARENTFOX SCHIFF LLP
2025 · fourth_quarter · Q4
EPA Clean Water Act pretreatment standards applicable to CWLP operations
Filing targets: Environmental Protection Agency (EPA)
ASSOCIATION OF AMERICAN RAILROADS via ARENTFOX SCHIFF LLP
2025 · fourth_quarter · Q4
Clean Air Act regulation of remanufactured locomotives
AMERICAN ELECTRIC POWER COMPANY, INC. via ARENTFOX SCHIFF LLP
2025 · fourth_quarter · Q4
Environmental Protection Agency (EPA) greenhouse gas regulations under Section 111 of the Clean Air Act EPA regulations of coal combustion residuals and permitting programs EPA effluent limitation guidelines Executive actions to extend power plant operations, address grid reliability and energy demand, and related power sector issues H.R. 3898 (PERMIT Act), regarding Clean Water Act effluent limitation guidelines H.R. 3900 (Water Quality Technology Availability Act), regarding Clean Water Act effluent limitation guidelines H.R. 4776 (SPEED Act), regarding amendment to the National Environmental Policy Act H.R. 161 (New Source Review Permitting Improvement Act), regarding permitting reform PFAS and Comprehensive Environmental Response Compensation and Liability (CERCLA) Act, regarding distribution of funds Siting and permitting reform, generally
Filing targets: Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
AMERICAN PUBLIC TRANSPORTATION ASSOCIATION via ARENTFOX SCHIFF LLP
2025 · fourth_quarter · Q4
H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), regarding Federal Transit Administration funding H. R. 5371 (Continuing Appropriations and Extensions Act, 2026), entire bill Policies related to Mass Transit Account generally
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding issues related to passenger rail policy, including liability insurance, Private Activity Bonds, and transit project approval processes H.R. 4900 and S. 2945 (Safe Transit Accountability Act), entire bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DURACELL US OPERATIONS, INC. via ARENTFOX SCHIFF LLP
2025 · fourth_quarter · RR
Department of Energy funding for domestic battery materials processing and battery production activities
BAUER COMPRESSORS, INC. via ARENTFOX SCHIFF LLP
2025 · fourth_quarter · RR
Tariff related advocacy. Section 232; IEEPA Reciprocal Tariffs.
PURITAN MEDICAL PRODUCTS CO., LLC via ARENTFOX SCHIFF LLP
2025 · third_quarter · Q3
Issues related to the PREP Act, which provides liability immunity for medical countermeasures during public health emergencies
Filing targets: Council of Economic Advisers (CEA), Executive Office of the President (EOP), White House Office
AMRIZE NORTH AMERICA INC. via ARENTFOX SCHIFF LLP
2025 · third_quarter · Q3
Clean Air Act compliance and enforcement matters concerning Paulding Cement Plant and broader issues related to 40 CFR Part 63, Subpart EEE
Filing targets: Environmental Protection Agency (EPA)
VISTRA CORP. via ARENTFOX SCHIFF LLP
2025 · third_quarter · Q3
H.R. 4553 (Energy and Water Development and Related AgenciesAppropriationsAct, 2026), regarding funding for Joppa Plant decommissioning project NOTE: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES
THE CHILDREN'S HOSPITAL OF PHILADELPHIA via ARENTFOX SCHIFF LLP
2025 · third_quarter · Q3
H.R. 1 (One Big Beautiful Bill Act), Title VII, Subtitle B, Chapter 1, regarding Medicaid program reforms Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
ORGANOGENESIS INC. via ARENTFOX SCHIFF LLP
2025 · third_quarter · Q3
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill NOTE: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ELECTRIC POWER COMPANY, INC. via ARENTFOX SCHIFF LLP
2025 · third_quarter · Q3
Environmental Protection Agency (EPA) greenhouse gas regulations under Section 111 of the Clean Air Act EPA regulations of coal combustion residuals and permitting programs EPA effluent limitation guidelines Executive actions to extend power plant operations, address grid reliability and energy demand, and related power sector issues H.R. 3898 (PERMIT Act), regarding Clean Water Act effluent limitation guidelines H.R. 3900 (Water Quality Technology Availability Act), regarding Clean Water Act effluent limitation guidelines H.R. 4776 (SPEED Act), regarding amendment to the National Environmental Policy Act NOTE: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
Filing targets: Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
CITY OF SPRINGFIELD, OFFICE OF PUBLIC UTILITIES DBA CITY WATER, LIGHT AND POWER via ARENTFOX SCHIFF LLP
2025 · third_quarter · Q3
EPA Clean Water Act pretreatment standards applicable to CWLP operations NOTE: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
Filing targets: Environmental Protection Agency (EPA)
AMERICAN PUBLIC TRANSPORTATION ASSOCIATION via ARENTFOX SCHIFF LLP
2025 · third_quarter · Q3
H.R. 1 (One Big Beautiful Bill Act), regarding electric vehicles H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), regarding Federal Transit Administration funding H. R. 5371 (Continuing Appropriations and Extensions Act, 2026), entire bill Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding and issues related to passenger rail policy, including liability insurance H.R. 4900 (Safe Transit Accountability Act), entire bill Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
FRAGRANCE CREATORS ASSOCIATION via ARENTFOX SCHIFF LLP
2025 · third_quarter · Q3
Implementation of Modernization of Cosmetics Regulation Act (MOCRA) regarding cosmetics ingredients and products NOTE: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
Policies related to corporate taxes and tax incentives, including research and experimentation expensing H.R. 1 (One Big Beautiful Bill Act), regarding corporate taxes and tax incentives, including research and experimentation expensing NOTE: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
ASSOCIATION OF AMERICAN RAILROADS via ARENTFOX SCHIFF LLP
2025 · third_quarter · Q3
Clean Air Act regulation of remanufactured locomotives NOTE: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
Filing targets: Environmental Protection Agency (EPA)
PURITAN MEDICAL PRODUCTS CO., LLC via ARENTFOX SCHIFF LLP
2025 · third_quarter · RR
Issues related to the PREP Act, which provides liability immunity for medical countermeasures during public health emergencies
MENTAL HEALTH ASSOCIATION OF NEW YORK CITY, INC. (DBA VIBRANT EMOTIONAL HEALTH) via ARENTFOX SCHIFF LLP
2025 · second_quarter · Q2
Policies surrounding and impacting mental health, suicide prevention, and the 988 Suicide & Crisis Lifeline Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
H.R. 2483 and S. 2121 (SUPPORT for Patients and Communities Reauthorization Act of 2025), regarding policies surrounding and impacting cybersecurity and the 988 Suicide & Crisis Lifeline Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
FRAGRANCE CREATORS ASSOCIATION via ARENTFOX SCHIFF LLP
2025 · second_quarter · Q2
Implementation of Modernization of Cosmetics Regulation Act (MOCRA) regarding cosmetics ingredients and products Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Policies related to corporate taxes and tax incentives, including research and experimentation expensing Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
AMRIZE NORTH AMERICA INC. via ARENTFOX SCHIFF LLP
2025 · second_quarter · Q2
Clean Air Act compliance and enforcement matters concerning Paulding Cement Plant
VISTRA CORP. via ARENTFOX SCHIFF LLP
2025 · second_quarter · Q2
Fiscal Year 2026 Department of Energy funding for Joppa Plant decommissioning project Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
THE CHILDREN'S HOSPITAL OF PHILADELPHIA via ARENTFOX SCHIFF LLP
2025 · second_quarter · Q2
Supplemental Nutrition Assistance Program generally Medicaid program reforms, including telemedicine and prior authorization issues Section 340B Drug Pricing program Drug pricing reforms generally Juvenile mental and behavioral health legislation generally "Food as medicine" nutrition programs generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Medicare "site neutral" payment policy generally Pediatric cancer research generally Pediatric access to cell and gene therapies generally National Institutes of Health program reforms generally H.R. 1 (One Big Beautiful Bill Act), Section 71115, regarding Medicaid provider taxes H.R. 1509 and S. 752 (Accelerating Kids Access to Care Act of 2025), all provisions Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMPUTER & COMMUNICATIONS INDUSTRY ASSOCIATION via ARENTFOX SCHIFF LLP
2025 · second_quarter · Q2
S. 836 (Children and Teens Online Privacy Protection Act), regarding online safety H.R. 3149 (App Store Accountability Act), regarding Competition Policy relating to antitrust enforcement H.R. 3209 (App Store Freedom Act), regarding Competition Policy relating to antitrust enforcement Draft legislation (American Innovation and Choice Online Act), regarding Competition Policy relating to antitrust enforcement Draft legislation (Open App Markets Act), regarding Competition Policy relating to antitrust enforcement Draft legislation (Journalism Competition and Preservation Act of 2023), regarding Competition Policy relating to antitrust enforcement Draft legislation (Kids Online Safety Act (KOSA)), regarding Competition Policy relating to antitrust enforcement Draft legislation (AMERICA Act or Advertising Middlemen Endangering Rigorous Internet Competition Accountability Act), regarding Competition Policy relating to antitrust enforcement Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
CITY OF SPRINGFIELD, OFFICE OF PUBLIC UTILITIES DBA CITY WATER, LIGHT AND POWER via ARENTFOX SCHIFF LLP
2025 · second_quarter · Q2
EPA Clean Water Act pretreatment standards applicable to CWLP operations Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: Environmental Protection Agency (EPA), Executive Office of the President (EOP)
ASSOCIATION OF AMERICAN RAILROADS via ARENTFOX SCHIFF LLP
2025 · second_quarter · Q2
Clean Air Act regulation of remanufactured locomotives Electronic labeling of locomotive engines Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: Environmental Protection Agency (EPA)
AMERICAN ELECTRIC POWER COMPANY, INC. via ARENTFOX SCHIFF LLP
2025 · second_quarter · Q2
Environmental Protection Agency (EPA) greenhouse gas regulations under Section 111 of the Clean Air Act EPA regulations of coal combustion residuals and permitting programs EPA effluent limitation guidelines Executive actions to extend power plant operations, address grid reliability and energy demand, and related power sector issues H.R. 3898 (PERMIT Act), regarding Clean Water Act effluent limitation guidelines H.R. 3900 (Water Quality Technology Availability Act), regarding Clean Water Act effluent limitation guidelines Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: Council on Environmental Quality (CEQ), Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES
AMERICAN PUBLIC TRANSPORTATION ASSOCIATION via ARENTFOX SCHIFF LLP
2025 · second_quarter · Q2
Fiscal Year 2026 funding for Federal Transit Administration programs H. Con. Res. 14, regarding Federal Transit Administration funding S. Con. Res. 7, regarding Federal Transit Administration funding H.R. 1 (One Big Beautiful Bill Act), regarding electric vehicles Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
AMRIZE NORTH AMERICA INC. via ARENTFOX SCHIFF LLP
2025 · second_quarter · RR
Clean Air Act compliance and enforcement matters concerning Paulding Cement Plant
HOLCIM (US) INC. via ARENTFOX SCHIFF LLP
2025 · second_quarter · 2T
Clean Air Act compliance and enforcement matters concerning Paulding Cement Plant
Filing targets: Environmental Protection Agency (EPA)
ASSOCIATION OF AMERICAN RAILROADS via ARENTFOX SCHIFF LLP
2025 · second_quarter · RR
Clean Air Act regulation of locomotive engines
HOLCIM (US) INC. via ARENTFOX SCHIFF LLP
2025 · second_quarter · RR
U.S. Environmental Protection Agency compliance and enforcement matters concerning Paulding Cement Plant
MENTAL HEALTH ASSOCIATION OF NEW YORK CITY, INC. (DBA VIBRANT EMOTIONAL HEALTH) via ARENTFOX SCHIFF LLP
2025 · first_quarter · 1A
Policies surrounding and impacting mental health, suicide prevention, and the 988 Suicide & Crisis Lifeline Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Draft legislation (SUPPORT for Patients and Communities Reauthorization Act), regarding policies surrounding and impacting cybersecurity and the 988 Suicide & Crisis Lifeline Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
AMERICAN ELECTRIC POWER COMPANY, INC. via ARENTFOX SCHIFF LLP
2025 · first_quarter · Q1
Environmental Protection Agency (EPA) greenhouse gas regulations under Section 111 of the Clean Air Act EPA regulations of coal combustion residuals and permitting programs EPA effluent limitation guidelines and standards Monarch butterfly listing under the Endangered Species Act Executive actions to extend power plant operations, address grid reliability and energy demand, and related power sector issues Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
VISTRA CORP. via ARENTFOX SCHIFF LLP
2025 · first_quarter · Q1
Fiscal Year 2025 and 2026 Department of Energy funding for Joppa Plant decommissioning project Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: SENATE
THERME GROUP US, LLC via ARENTFOX SCHIFF LLP
2025 · first_quarter · Q1
Potential locations of Therme resorts in the United States Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
THE CHILDREN'S HOSPITAL OF PHILADELPHIA via ARENTFOX SCHIFF LLP
2025 · first_quarter · Q1
Supplemental Nutrition Assistance Program generally Medicaid program reforms, including telemedicine and prior authorization issues Section 340B Drug Pricing program Drug pricing reforms generally Juvenile mental and behavioral health legislation generally "Food as medicine" nutrition programs generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Medicare "site neutral" payment policy generally Pediatric cancer research generally Pediatric access to cell and gene therapies generally National Institutes of Health program reforms generally Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORGANOGENESIS INC. via ARENTFOX SCHIFF LLP
2025 · first_quarter · Q1
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MENTAL HEALTH ASSOCIATION OF NEW YORK CITY, INC. (DBA VIBRANT EMOTIONAL HEALTH) via ARENTFOX SCHIFF LLP
2025 · first_quarter · Q1
Policies surrounding and impacting mental health, suicide prevention, and the 988 Suicide & Crisis Lifeline Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Draft legislation (SUPPORT for Patients and Communities Reauthorization Act), regarding policies surrounding and impacting cybersecurity and the 988 Suicide & Crisis Lifeline Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
INFECTIOUS DISEASES SOCIETY OF AMERICA via ARENTFOX SCHIFF LLP
2025 · first_quarter · Q1
Fiscal Year 2026 funding for Bio-Preparedness Workforce Pilot Program, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H. Con. Res 14, regarding funding for infectious diseases programs generally S. Con. Res 7, regarding funding for infectious diseases programs generally H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding funding for Infectious diseases programs FY 2025 funding for infectious diseases programs generally Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRAGRANCE CREATORS ASSOCIATION via ARENTFOX SCHIFF LLP
2025 · first_quarter · Q1
Implementation of Modernization of Cosmetics Regulation Act (MOCRA) regarding cosmetics ingredients and products Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Policies related to corporate taxes and tax incentives, including research and experimentation expensing Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
COMPUTER & COMMUNICATIONS INDUSTRY ASSOCIATION via ARENTFOX SCHIFF LLP
2025 · first_quarter · Q1
Policy regarding data privacy Draft legislation (Stop CSAM Act), regarding online protections Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Draft legislation (American Innovation and Choice Online Act), regarding Competition Policy relating to antitrust enforcement Draft legislation (Open App Markets Act), regarding Competition Policy relating to antitrust enforcement Draft legislation (Journalism Competition and Preservation Act of 2023), regarding Competition Policy relating to antitrust enforcement Draft legislation (Kids Online Safety Act (KOSA)), regarding Competition Policy relating to antitrust enforcement Draft legislation (AMERICA Act or Advertising Middlemen Endangering Rigorous Internet Competition Accountability Act), regarding Competition Policy relating to antitrust enforcement Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
CITY OF SPRINGFIELD, OFFICE OF PUBLIC UTILITIES DBA CITY WATER, LIGHT AND POWER via ARENTFOX SCHIFF LLP
2025 · first_quarter · Q1
EPA Clean Water Act pretreatment standards applicable to CWLP operations Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
AMERICAN PUBLIC TRANSPORTATION ASSOCIATION via ARENTFOX SCHIFF LLP
2025 · first_quarter · Q1
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL RECYCLING GROUP (IRG) via ARENTFOX SCHIFF LLP
2025 · first_quarter · 1T
Request loan program support for recycling plant facility being proposed in Erie, PA, to help keep plastic out of landfills Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COOP CAREERS, INC. via ARENTFOX SCHIFF LLP
2025 · first_quarter · RR
Federal engagement before Congress and federal agencies to support adult education funding
Federal engagement before Congress and federal agencies to support adult education funding
CITY OF SPRINGFIELD, OFFICE OF PUBLIC UTILITIES DBA CITY WATER, LIGHT AND POWER via ARENTFOX SCHIFF LLP
2025 · first_quarter · RR
EPA Clean Water Act pretreatment standards applicable to CWLP operations
AMERICAN ELECTRIC POWER COMPANY, INC. via ARENTFOX SCHIFF LLP
2025 · first_quarter · RR
Environmental Protection Agency (EPA) regulations under Clean Air Act Section 111(b) and (d) performance standards; EPA regulations of coal combustion residuals; and EPA effluent limitation guidelines and standards
VISTRA CORP. via ARENTFOX SCHIFF LLP
2025 · first_quarter · RR
Department of Energy funding for Joppa Plant decommissioning project
THE CHILDREN'S HOSPITAL OF PHILADELPHIA via ARENTFOX SCHIFF LLP
2024 · fourth_quarter · 4A
Medicaid program reforms, including telemedicine and prior authorization issues Section 340B Drug Pricing program, including H.R. 5378 (Lower Costs, More Transparency Act), Section 202 Drug pricing reforms generally Juvenile mental and behavioral health legislation generally "Food as medicine" nutrition programs generally H.R. 3884 and S. 1852 (Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023), all provisions H.R. 3391 (Gabriella Miller Kids First Research Act 2.0), all provisions H.R. 3887 (Childrens Hospital GME Support Reauthorization Act of 2023), all provisions Medicare "site neutral" payment policy generally, including H.R. 5378 (Lower Costs, More Transparency Act), Section 203 Pediatric cancer research generally Pediatric access to cell and gene therapies generally H.R. 4758 (Accelerating Kids Access to Care Act), all provisions H.R. 7213 (Autism Collaboration, Accountability, Research, Education, and Support Act of 2024), all provisions H.R. 8260 and S. 4350 (Hospital Inpatient Services Modernization Act), all provisions H.R. 10545 (American Relief Act, 2025), regarding HHS program funding and Medicaid program reform provisions National Institutes of Health program reforms generally S. 904 (Sickle Cell Disease Comprehensive Care Act), all provisions Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
INFECTIOUS DISEASES SOCIETY OF AMERICA via ARENTFOX SCHIFF LLP
2024 · fourth_quarter · 4A
H.R. 2940 and S. 1355 (PASTEUR Act of 2023), all provisions H.R. 4420 (Preparedness and Response Reauthorization Act), all provisions H.R. 4421 (Preparing for all Hazards and Pathogens Reauthorization Act), all provisions S. 2333 (Pandemic and All-Hazards Preparedness and Response Act), all provisions Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ASSOCIATION OF TEACHING HEALTH CENTERS via ARENTFOX SCHIFF LLP
2024 · fourth_quarter · 4A
Implementation of the Teaching Health Center Graduate Medical Education (THCGME) program generally Reauthorization of the Teaching Health Center Graduate Medical Education (THCGME) program H.R. 5378 (Lower Costs, More Transparency Act), Section 301, regarding reauthorization of THCGME program S. 2840 (Bipartisan Primary Care and Health Workforce Act), Section 101, regarding reauthorization of THCGME program H.R. 10545 (American Relief Act, 2025), Division C, Title II, Sec. 3201, regarding funding for THCGME program Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE CHILDREN'S HOSPITAL OF PHILADELPHIA via ARENTFOX SCHIFF LLP
2024 · fourth_quarter · Q4
Medicaid program reforms, including telemedicine and prior authorization issues Section 340B Drug Pricing program, including H.R. 5378 (Lower Costs, More Transparency Act), Section 202 Drug pricing reforms generally Juvenile mental and behavioral health legislation generally "Food as medicine" nutrition programs generally H.R. 3884 and S. 1852 (Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023), all provisions H.R. 3391 (Gabriella Miller Kids First Research Act 2.0), all provisions H.R. 3887 (Childrens Hospital GME Support Reauthorization Act of 2023), all provisions Medicare "site neutral" payment policy generally, including H.R. 5378 (Lower Costs, More Transparency Act), Section 203 Pediatric cancer research generally Pediatric access to cell and gene therapies generally H.R. 4758 (Accelerating Kids Access to Care Act), all provisions H.R. 7213 (Autism Collaboration, Accountability, Research, Education, and Support Act of 2024), all provisions H.R. 8260 and S. 4350 (Hospital Inpatient Services Modernization Act), all provisions H.R. 10545 (American Relief Act, 2025), regarding HHS program funding and Medicaid program reform provisions National Institutes of Health program reforms generally S. 904 (Sickle Cell Disease Comprehensive Care Act), all provisions
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INFECTIOUS DISEASES SOCIETY OF AMERICA via ARENTFOX SCHIFF LLP
2024 · fourth_quarter · Q4
H.R. 2940 and S. 1355 (PASTEUR Act of 2023), all provisions H.R. 4420 (Preparedness and Response Reauthorization Act), all provisions H.R. 4421 (Preparing for all Hazards and Pathogens Reauthorization Act), all provisions S. 2333 (Pandemic and All-Hazards Preparedness and Response Act), all provisions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ASSOCIATION OF TEACHING HEALTH CENTERS via ARENTFOX SCHIFF LLP
2024 · fourth_quarter · Q4
Implementation of the Teaching Health Center Graduate Medical Education (THCGME) program generally Reauthorization of the Teaching Health Center Graduate Medical Education (THCGME) program H.R. 5378 (Lower Costs, More Transparency Act), Section 301, regarding reauthorization of THCGME program S. 2840 (Bipartisan Primary Care and Health Workforce Act), Section 101, regarding reauthorization of THCGME program H.R. 10545 (American Relief Act, 2025), Division C, Title II, Sec. 3201, regarding funding for THCGME program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Implementation of P.L. 114-182 (Frank R. Lautenberg Chemical Safety for the 21st Century Act), regarding provisions related to the approval of new chemicals and risk evaluations Impacts of trade issues on chemicals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Permitting reform
H.R. 8646 (Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027), regarding implementation of Modernization of Cosmetics Regulation Act (MoCRA) H.R. 5371 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026), Division F, Title V, regarding implementation of Modernization of Cosmetics Regulation Act (MoCRA) H.R.9171 (Department of the Interior, Environment, and Related Agencies Appropriations Act, 2027), regarding continued implementation of TSCA's fee authority
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Implementation of P.L. 114-182 (Frank R. Lautenberg Chemical Safety for the 21st Century Act), regarding provisions related to the approval of new chemicals and risk evaluations Impacts of trade issues on chemicals
Policies related to corporate taxes and tax incentives, including research and experimentation expensing H.R. 1 (One Big Beautiful Bill Act), regarding corporate taxes and tax incentives, including research and experimentation expensing
Permitting reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
Implementation of P.L. 114-182 (Frank R. Lautenberg Chemical Safety for the 21st Century Act), regarding provisions related to the approval of new chemicals and risk evaluations Impacts of trade issues on chemicals
Permitting reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 4121 and S. 2256 (Agriculture, Rural Development, Food and Drug Administration, and Related AgenciesAppropriationsAct, 2026), regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA)FY26 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, Title VI, regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA) NOTE: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
Implementation of P.L. 114-182 (Frank R. Lautenberg Chemical Safety for the 21st Century Act), regarding provisions related to the approval of new chemicals and risk evaluations Impacts of trade issues on chemicals NOTE: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 912 and S. 1007 (9-8-8 Lifeline Cybersecurity Responsibility Act), regarding funding for the 988 Suicide & Crisis Lifeline Fiscal Year 2026 Departments of Labor, Health and Human Services, and Education regarding funding for the 988 Suicide & Crisis Lifeline Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Policies related to recruiting and retaining a mental health workforce Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Fiscal Year 2026 Department of Agriculture funding regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA)FY26 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, Title VI, regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA) Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Implementation of P.L. 114-182 (Frank R. Lautenberg Chemical Safety for the 21st Century Act), regarding provisions related to the approval of new chemicals and risk evaluations Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Policy regarding data privacy Draft legislation (Stop CSAM Act), regarding online protections Issues related to broadband access Issues related to Artificial Intelligence Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding funding for the 988 Suicide & Crisis Lifeline H.R. 912 and S. 1007 (9-8-8 Lifeline Cybersecurity Responsibility Act), regarding funding for the 988 Suicide & Crisis Lifeline Fiscal Year 2025 and 2026 Departments of Labor, Health and Human Services, and Education regarding funding for the 988 Suicide & Crisis Lifeline Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Policies related to recruiting and retaining a mental health workforce Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding funding for the 988 Suicide & Crisis Lifeline H.R. 912 and S. 1007 (9-8-8 Lifeline Cybersecurity Responsibility Act), regarding funding for the 988 Suicide & Crisis Lifeline Fiscal Year 2025 and 2026 Departments of Labor, Health and Human Services, and Education regarding funding for the 988 Suicide & Crisis Lifeline Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Policies related to recruiting and retaining a mental health workforce Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA)FY26 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, Title VI, regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA) Fiscal Year 2025 and 2026 Department of Agriculture funding regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA)FY26 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, Title VI, regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA) Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Implementation of P.L. 114-182 (Frank R. Lautenberg Chemical Safety for the 21st Century Act), regarding provisions related to the approval of new chemicals and risk evaluations Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE